Early results from researchers at the University of Wisconsin-Madison (UWM) Medical School show that juice from the pomegranate slows the progression of cancer, particularly prostate cancer.

In clinical tests, the higher the dose of pomegranate extract the cancerous cells received, the more cells died. The pomegranate, native to the Middle East, is rich in anti-oxidant and anti-inflammatory properties.

According to the study, more than 230,000 new cases of prostate cancer are expected to be diagnosed in the United States alone, and the prognosis is grim for patients whose disease has metastasized.

Prostate cancer is the most common invasive cancer, and the second-leading cause of cancer death in American men, according to UWM.

For more information, visit www.news.wisc.edu.